• Mashup Score: 0

    AuthorsVenkatraman RadhakrishnanCancer Institute (WIA), Chennai, IndiaVenkatraman Radhakrishnan, Vidhya Gopalakrishnan, Vamsi Vihari, Venkata Siva Kiran Kumar Dasapathi, Swaminathan Rajaraman, Jayachandran Perumal Kalaiyarasi, Priya Iyer, Arvind Krishnamurthy, Sridevi V, Surendran VeeraiahOrganizationsCancer Institute (WIA), Chennai, IndiaAbstract DisclosuresResearch FundingInstitutional…

    Tweet Tweets with this article
    • No, long term low dose dexamethasone (4 mg/day for 12 weeks) compared to placebo does not improve fatigue in patients receiving palliative chemotherapy. #ASCO23 https://t.co/mvUnoBmE8h https://t.co/ieT9aA4Pub

  • Mashup Score: 2

    The SIOP Education and Training Committee is glad to announce the launch of the “Childhood Cancer Early Diagnosis and Appropriate Referral (CEDAR) project”, in collaboration with the International Pediatric Association (IPA). The main objective of the CEDAR Project is to improve the knowledge and understanding of general health care providers, including paediatricians, family practitioners,

    Tweet Tweets with this article
    • RT @CancerPOINTE: 2/2 For future webinars + videos of previous webinars: https://t.co/kMRQMTgjdb Thanks to all that attended and thanks to…

  • Mashup Score: 4
    Wolters Kluwer Health - 2 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • RT @CRSTonline: Our new issue is online at https://t.co/lLzLqhVbsq. Please let us know whether you like or hate any articles in particular,…

  • Mashup Score: 0

    PURPOSE The regimens approved for the treatment of advanced head and neck squamous cell carcinoma are accessible to only 1%-3% of patients in low- and middle-income countries because of their cost. In our previous study, metronomic chemotherapy improved survival in this setting. Retrospective data suggest that a low dose of nivolumab may be efficacious. Hence, we aimed to assess whether the…

    Tweet Tweets with this article
    • Research from India can impact the whole world. An amazing study on low dose immunotherapy from TMH. This is the real game changer and breakthrough treatment. Congratulations @DrVijayPatil11 @VanitaNoronha https://t.co/pwjhTVcUlb